BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27803950)

  • 1. Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy.
    Weijer R; Clavier S; Zaal EA; Pijls MM; van Kooten RT; Vermaas K; Leen R; Jongejan A; Moerland PD; van Kampen AH; van Kuilenburg AB; Berkers CR; Lemeer S; Heger M
    Cell Mol Life Sci; 2017 Mar; 74(6):1133-1151. PubMed ID: 27803950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
    Weijer R; Broekgaarden M; van Golen RF; Bulle E; Nieuwenhuis E; Jongejan A; Moerland PD; van Kampen AH; van Gulik TM; Heger M
    BMC Cancer; 2015 Dec; 15():1014. PubMed ID: 26705830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy.
    Weijer R; Broekgaarden M; Krekorian M; Alles LK; van Wijk AC; Mackaaij C; Verheij J; van der Wal AC; van Gulik TM; Storm G; Heger M
    Oncotarget; 2016 Jan; 7(3):3341-56. PubMed ID: 26657503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallated phthalocyanines and their hydrophilic derivatives for multi-targeted oncological photodynamic therapy.
    Dias LM; de Keijzer MJ; Ernst D; Sharifi F; de Klerk DJ; Kleijn TG; Desclos E; Kochan JA; de Haan LR; Franchi LP; van Wijk AC; Scutigliani EM; Fens MH; Barendrecht AD; Cavaco JEB; Huang X; Xu Y; Pan W; den Broeder MJ; Bogerd J; Schulz RW; Castricum KC; Thijssen VL; Cheng S; Ding B; Krawczyk PM; Heger M;
    J Photochem Photobiol B; 2022 Sep; 234():112500. PubMed ID: 35816857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.
    de Keijzer MJ; de Klerk DJ; de Haan LR; van Kooten RT; Franchi LP; Dias LM; Kleijn TG; van Doorn DJ; Heger M;
    Methods Mol Biol; 2022; 2451():285-403. PubMed ID: 35505024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic treatment with hexyl-aminolevulinate mediates reversible thiol oxidation in core oxidative stress signaling proteins.
    Helander L; Sharma A; Krokan HE; Plaetzer K; Krammer B; Tortik N; Gederaas OA; Slupphaug G; Hagen L
    Mol Biosyst; 2016 Mar; 12(3):796-805. PubMed ID: 26742548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma.
    Bae BC; Yang SG; Jeong S; Lee DH; Na K; Kim JM; Costamagna G; Kozarek RA; Isayama H; Deviere J; Seo DW; Nageshwar Reddy D
    Biomaterials; 2014 Oct; 35(30):8487-95. PubMed ID: 25043500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways in cell death and survival after photodynamic therapy.
    Moor AC
    J Photochem Photobiol B; 2000 Aug; 57(1):1-13. PubMed ID: 11100832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.
    Broekgaarden M; Weijer R; van Gulik TM; Hamblin MR; Heger M
    Cancer Metastasis Rev; 2015 Dec; 34(4):643-90. PubMed ID: 26516076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel zinc‑ and silicon‑phthalocyanines as photosensitizers for photodynamic therapy of cholangiocarcinoma.
    Schmidt J; Kuzyniak W; Berkholz J; Steinemann G; Ogbodu R; Hoffmann B; Nouailles G; Gürek AG; Nitzsche B; Höpfner M
    Int J Mol Med; 2018 Jul; 42(1):534-546. PubMed ID: 29693115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
    Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
    Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorin e6-mediated photodynamic therapy promotes collagen production and suppresses MMPs expression via modulating AP-1 signaling in P. acnes-stimulated HaCaT cells.
    Ryu AR; Lee MY
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():71-77. PubMed ID: 28807774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained ERK [corrected] inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy.
    Weyergang A; Selbo PK; Berg K
    Biochim Biophys Acta; 2013 Mar; 1830(3):2659-70. PubMed ID: 23671927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epidermal growth factor receptor-targeted and endoplasmic reticulum-localized organic photosensitizer toward photodynamic anticancer therapy.
    Zhao X; Ma H; Chen J; Zhang F; Jia X; Xue J
    Eur J Med Chem; 2019 Nov; 182():111625. PubMed ID: 31442683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NF-κB/Snail/RKIP loop in the response of tumor cells to photodynamic therapy.
    Rapozzi V; Umezawa K; Xodo LE
    Lasers Surg Med; 2011 Sep; 43(7):575-85. PubMed ID: 22057485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles.
    Tsai WH; Yu KH; Huang YC; Lee CI
    Int J Nanomedicine; 2018; 13():903-916. PubMed ID: 29445279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.
    Kiesslich T; Wolkersdörfer G; Neureiter D; Salmhofer H; Berr F
    Photochem Photobiol Sci; 2009 Jan; 8(1):23-30. PubMed ID: 19247524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance.
    Olsen CE; Weyergang A; Edwards VT; Berg K; Brech A; Weisheit S; Høgset A; Selbo PK
    Biochem Pharmacol; 2017 Nov; 144():63-77. PubMed ID: 28784290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of photosensitizer-mediated photodynamic therapy by gene expression profiling.
    Liu KH; Wang CP; Chang MF; Chung YW; Lou PJ; Lin JH
    Hum Exp Toxicol; 2014 Jun; 33(6):629-37. PubMed ID: 24064908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy.
    Stott B; Korbelik M
    Cancer Immunol Immunother; 2007 May; 56(5):649-58. PubMed ID: 16947020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.